Literature DB >> 16862463

Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection.

Daiana Stolz1, Mirjam Christ-Crain, Mikael M Gencay, Roland Bingisser, Peter R Huber, Beat Müller, Michael Tamm.   

Abstract

BACKGROUND: Lower respiratory tract infections (LRTI) account for the majority of all antibiotics prescribed in the clinical practice, irrespective of the fact that most cases are self-limiting. Using the outcome and microbiology findings as gold standard, we determined sensitivity, specificity, positive and negative predictive values of common used signs and symptoms of bacterial LRTI requiring antibiotic therapy. PATIENTS: 243 consecutive patients with suspected LRTI admitted to a tertiary care hospital.
RESULTS: Bacterial LRTI requiring antibiotic therapy and self-limiting LRTI were diagnosed in 32 and 86 patients, respectively. Assessing these two groups, sputum, dyspnea, crackles, fever and leukocytes (WBC) were insensitive and unspecific parameters for the diagnosis of bacterial LRTI requiring antibiotic therapy. Cough was sensitive (93.8%) but unspecific (5.8%). The sensitivity of infiltrates, C-reactive protein (CRP) >50 mg/L and procalcitonin (PCT) >0.1 ng/mL was 96.9%, 93.8% and 93.8%, respectively. PCT >0.25 ng/mL showed the highest specificity (97.7%), followed by WBC >16 x 109/L (94.2%) and CRP >100 mg/L (91.9%). The sensitivity of WBC >16 x 109/L was low (37.5%).
CONCLUSION: The overall sensitivity and specificity of signs and symptoms for bacterial LRTI requiring antibiotic therapy was poor. Obtaining a chest-X-ray with infiltrates and determining CRP at a cut-off value of 50 mg/L or PCT at a cutoff value of 0.1 ng/mL was required to ascertain the need for antibiotics in LRTI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862463     DOI: 2006/27/smw-11271

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  10 in total

1.  Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.

Authors:  Yan-Ping Ye; Hang Zhao; Tao Kang; Li-Hua Zhao; Ning Li; Jing Chen; Xiao-Xia Peng
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

2.  The association of positive chest radiograph and laboratory parameters with community acquired pneumonia in children.

Authors:  Dhairya Lakhani; Prasad Muley
Journal:  J Clin Diagn Res       Date:  2013-08-01

3.  Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial.

Authors:  Robin Brittain-Long; Johan Westin; Sigvard Olofsson; Magnus Lindh; Lars-Magnus Andersson
Journal:  BMC Med       Date:  2011-04-26       Impact factor: 8.775

4.  Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study.

Authors:  Lena M Mayer; Christian Kahlert; Frank Rassouli; Pietro Vernazza; Werner C Albrich
Journal:  Pneumonia (Nathan)       Date:  2017-02-25

5.  Impact of BioFire FilmArray respiratory panel results on antibiotic days of therapy in different clinical settings.

Authors:  Jenna J Manatrey-Lancaster; Amanda M Bushman; Meagan E Caligiuri; Rossana Rosa
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-06-24

6.  The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.

Authors:  Dejie Gao; Xincan Chen; He Wu; Haidong Wei; Jinling Wu
Journal:  Exp Ther Med       Date:  2017-05-23       Impact factor: 2.447

7.  Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections.

Authors:  Wesley H Self; Jeffrey Rosen; Stephan C Sharp; Michael R Filbin; Peter C Hou; Amisha D Parekh; Michael C Kurz; Nathan I Shapiro
Journal:  J Clin Med       Date:  2017-10-07       Impact factor: 4.241

8.  C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis.

Authors:  Xing An; Chuantao Zhang; Xiangwen Weng; Wei Xiao; Zengtao Sun; Zhu Zeng; Qingsong Huang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

Review 9.  New markers in pneumonia.

Authors:  Chao-Wen Cheng; Ming-Hsien Chien; Shih-Chi Su; Shun-Fa Yang
Journal:  Clin Chim Acta       Date:  2013-02-04       Impact factor: 3.786

10.  Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.

Authors:  Kristina Vermeersch; Ann Belmans; Kris Bogaerts; Iwein Gyselinck; Nina Cardinaels; Maria Gabrovska; Joseph Aumann; Ingel K Demedts; Jean-Louis Corhay; Eric Marchand; Hans Slabbynck; Christel Haenebalcke; Stefanie Vermeersch; Geert M Verleden; Thierry Troosters; Vincent Ninane; Guy G Brusselle; Wim Janssens
Journal:  Respir Res       Date:  2019-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.